LATEST NEWS & PUBLICATIONS
Mastering Best Practices: Vetting Previously Marketed Pharmaceutical Drug Acquisitions
MASTERING BEST PRACTICES: Vetting Previously Marketed Pharmaceutical Drug AcquisitionsPharmaceutical manufacturers considering the acquisition of pre-existing drugs face the challenge of conducting a meticulous and comprehensive analysis across a spectrum of...
The 2024 Medicaid AMP Cap Removal: What Pharma Manufacturers Need to Know
2024 AMP CAP REMOVAL What You Need To Know2024 AMP CAP REMOVAL – WHAT PHARMA MANUFACTURERS NEED TO KNOWThe 2024 Medicaid AMP cap removal will be effective January 1st, 2024, and may have sweeping impacts for drug manufacturers participating in the Medicaid program....
2023 Drug Wastage Rule to Impact Pharma Manufacturers
2023 DRUG WASTAGE RULE TO IMPACTPHARMA MANUFACTURERSPharmaceutical manufacturers continue to experience regulatory and program changes that result in new rebates and/or penalties which have the potential to negatively impact profitability. Last year, the Inflation...
OUR DIFFERENCE
Access
- Direct access to your analyst and company leadership
- Available 24/7 to support your needs
Accuracy
- Apply discipline to fully compliant SOPs
- All deliverables subject to strict layers of reviews and audits
Dependability
- Consistent ownership & business partners
- Vested in your long-term success
Transparency
- Clients own all data
- Full access to all scrubbed data, computations and processes
Problems Solved — Opportunities Leveraged.
Find out how we can support your critical analytic, processing and financial functions.